169 related articles for article (PubMed ID: 32185564)
1. The Opposed Effects of Polyvinylpyrrolidone K30 on Dissolution and Precipitation for Indomethacin Supersaturating Drug Delivery Systems.
Wang W; Li M; Yang Q; Liu Q; Ye M; Yang G
AAPS PharmSciTech; 2020 Mar; 21(3):107. PubMed ID: 32185564
[TBL] [Abstract][Full Text] [Related]
2. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
Sun DD; Ju TC; Lee PI
Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548
[TBL] [Abstract][Full Text] [Related]
3. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.
Prasad D; Chauhan H; Atef E
J Pharm Sci; 2014 Nov; 103(11):3511-3523. PubMed ID: 25196860
[TBL] [Abstract][Full Text] [Related]
4. Characterization of physico-mechanical properties of indomethacin and polymers to assess their suitability for hot-melt extrusion processs as a means to manufacture solid dispersion/solution.
Chokshi RJ; Sandhu HK; Iyer RM; Shah NH; Malick AW; Zia H
J Pharm Sci; 2005 Nov; 94(11):2463-74. PubMed ID: 16200544
[TBL] [Abstract][Full Text] [Related]
5. Role of Molecular Interactions for Synergistic Precipitation Inhibition of Poorly Soluble Drug in Supersaturated Drug-Polymer-Polymer Ternary Solution.
Prasad D; Chauhan H; Atef E
Mol Pharm; 2016 Mar; 13(3):756-65. PubMed ID: 26866895
[TBL] [Abstract][Full Text] [Related]
6. Factors Affecting the Dissolution of Indomethacin Solid Dispersions.
Zhang W; Zhang CN; He Y; Duan BY; Yang GY; Ma WD; Zhang YH
AAPS PharmSciTech; 2017 Nov; 18(8):3258-3273. PubMed ID: 28584898
[TBL] [Abstract][Full Text] [Related]
7. Physicochemical characterization and dissolution study of solid dispersions of Lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30.
Patel RP; Patel MM
Pharm Dev Technol; 2007; 12(1):21-33. PubMed ID: 17484141
[TBL] [Abstract][Full Text] [Related]
8. Polymer/lipid interplay in altering in vitro supersaturation and plasma concentration of a model poorly soluble drug.
Peng R; Huang J; He L; Zhao L; Wang C; Wei W; Xia T; Mao Y; Wen Y; Wang L; Yang J
Eur J Pharm Sci; 2020 Apr; 146():105262. PubMed ID: 32060005
[TBL] [Abstract][Full Text] [Related]
9. Impact of Eudragit EPO and hydroxypropyl methylcellulose on drug release rate, supersaturation, precipitation outcome and redissolution rate of indomethacin amorphous solid dispersions.
Xie T; Gao W; Taylor LS
Int J Pharm; 2017 Oct; 531(1):313-323. PubMed ID: 28844901
[TBL] [Abstract][Full Text] [Related]
10. Dissolution and precipitation behavior of amorphous solid dispersions.
Alonzo DE; Gao Y; Zhou D; Mo H; Zhang GGZ; Taylor LS
J Pharm Sci; 2011 Aug; 100(8):3316-3331. PubMed ID: 21607951
[TBL] [Abstract][Full Text] [Related]
11. Physicochemical characterization and in vitro dissolution studies of solid dispersions of ketoprofen with PVP K30 and d-mannitol.
Yadav PS; Kumar V; Singh UP; Bhat HR; Mazumder B
Saudi Pharm J; 2013 Jan; 21(1):77-84. PubMed ID: 24109206
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Microcentrifuge Dissolution Method as a Tool for Spray-Dried Dispersion.
Wu B; Li J; Wang Y
AAPS J; 2016 Mar; 18(2):346-53. PubMed ID: 26831250
[TBL] [Abstract][Full Text] [Related]
13. Molecular structure and impact of amorphization strategies on intrinsic dissolution of spray dried indomethacin.
Li Y; Rantanen J; Yang M; Bohr A
Eur J Pharm Sci; 2019 Mar; 129():1-9. PubMed ID: 30553059
[TBL] [Abstract][Full Text] [Related]
14. Characterization and physical stability of spray dried solid dispersions of probucol and PVP-K30.
Thybo P; Pedersen BL; Hovgaard L; Holm R; Mullertz A
Pharm Dev Technol; 2008; 13(5):375-86. PubMed ID: 18720236
[TBL] [Abstract][Full Text] [Related]
15. Dissolution kinetics for coprecipitates of diflunisal with PVP K30.
Rodríguez-Espinosa C; Martínez-Ohárriz MC; Martín C; Goñi MM; Vélaz I; Sánchez M
Eur J Drug Metab Pharmacokinet; 1998; 23(2):109-12. PubMed ID: 9725466
[TBL] [Abstract][Full Text] [Related]
16. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods.
Sethia S; Squillante E
Int J Pharm; 2004 Mar; 272(1-2):1-10. PubMed ID: 15019063
[TBL] [Abstract][Full Text] [Related]
17. Effects of tablet formulation and subsequent film coating on the supersaturated dissolution behavior of amorphous solid dispersions.
Sakai T; Hirai D; Kimura SI; Iwao Y; Itai S
Int J Pharm; 2018 Apr; 540(1-2):171-177. PubMed ID: 29447848
[TBL] [Abstract][Full Text] [Related]
18. Effect of Variability of Physical Properties of Povidone K30 on Crystallization and Drug-Polymer Miscibility of Celecoxib-Povidone K30 Amorphous Solid Dispersions.
Phadke C; Sharma J; Sharma K; Bansal AK
Mol Pharm; 2019 Oct; 16(10):4139-4148. PubMed ID: 31454247
[TBL] [Abstract][Full Text] [Related]
19. Preparation, Characterization and Stability Studies of Glassy Solid Dispersions of Indomethacin using PVP and Isomalt as carriers.
Khodaverdi E; Khalili N; Zangiabadi F; Homayouni A
Iran J Basic Med Sci; 2012 May; 15(3):820-32. PubMed ID: 23493157
[TBL] [Abstract][Full Text] [Related]
20. Stabilization of low glass transition temperature indomethacin formulations: impact of polymer-type and its concentration.
Chokshi RJ; Shah NH; Sandhu HK; Malick AW; Zia H
J Pharm Sci; 2008 Jun; 97(6):2286-98. PubMed ID: 17879977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
